Table 3: Multivariate analysis of risk factors associated with BM in NSCLC.
Variabe |
OR |
95%CI |
p |
CI (Yes vs No) |
2.921 |
1.242-6.873 |
0.014 |
T status (T1-T2 vs T3-T4) |
1.892 |
0.952-3.760 |
0.069 |
LN status (N0-N1 vs N2-N3) |
2.828 |
1.262-6.337 |
0.012 |
Location (lobe) (Middle vs Not middle) |
3.148 |
1.158-8.558 |
0.025 |
Histology (Ad vs Not Ad) |
4.032 |
1.542-10.542 |
0.004 |
D-D (ng/ml) (>500 vs ≤500) |
1.091 |
0.503-2.367 |
0.825 |
CEA (ng/ml) (>5 vs ≤5) |
1.370 |
0.657-2.858 |
0.401 |
CA125 (U/ml) (>35 vs ≤35) |
1.815 |
0.893-3.690 |
0.100 |
BM: brain metastasis; CI: cerebral infarction; D-D: D-Dimer; CEA: carcinoembryonic antigen; CA125: carbohydrate antigen 125.